Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

NCT02158702 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Relapse After Use of Lenalidomide and Bortezomib

Interventions

DRUG: Pomalidomide and Dexamethasone

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]